michaels resignation, page-2

loss of CEO makes me uneasy just after losing head of chemistry. also three other senior staff in last 6 months. That is a large attrition rate for such a small company.

So many people leaving is a bit weird in my view. Anyone know how relationships are on the Board?

My fear is they know something we don't and are getting out.

This statement was interesting: 'evaluate business priorities across the product development alternatives.'

I would guess that means some products are going to be scaled back/dumped. The biggie of course would be lenes. One year now since the unsuccessful human trials, and months since the co-development company [one in take-over talks] was meant to be back in development.

Interesting days.